Parenting Bulletin    
Recent News |  Archives |  Tags |  Newsletter |  Message Board/Forum |  About |  Links |  Subscribe to ParentingBulletin.com RSS Feed Subscribe


More Articles
Improvements in fuel cell designImprovements in fuel cell design

Rediscovering Venus to find faraway earths

Archaeologists discover bronze remains of Iron Age chariot

Researchers resolve the Karakoram glacier anomaly, a cold case of climate science

Fish tale: New study evaluates antibiotic content in farm-raised fishFish tale: New study evaluates antibiotic content in farm-raised fish

New 3-D display technology promises greater energy efficiencyNew 3-D display technology promises greater energy efficiency

Researchers break nano barrier to engineer the first protein microfiberResearchers break nano barrier to engineer the first protein microfiber

Magnetic mirrors enable new technologies by reflecting light in uncanny ways

Structure of an iron-transport protein revealedStructure of an iron-transport protein revealed

First step: From human cells to tissue-engineered esophagusFirst step: From human cells to tissue-engineered esophagus

Lift weights, improve your memory

Spiders: Survival of the fittest group

Autophagy helps fast track stem cell activationAutophagy helps fast track stem cell activation

Myelin vital for learning new practical skillsMyelin vital for learning new practical skills

More physical activity improved school performanceMore physical activity improved school performance

Around the world in 400,000 years: The journey of the red foxAround the world in 400,000 years: The journey of the red fox

Engineering new vehicle powertrainsEngineering new vehicle powertrains

Active aging is much more than exerciseActive aging is much more than exercise

Study: New device can slow, reverse heart failureStudy: New device can slow, reverse heart failure

Are the world's religions ready for ET?Are the world's religions ready for ET?

Gut bacteria, artificial sweeteners and glucose intoleranceGut bacteria, artificial sweeteners and glucose intolerance

Recreating the stripe patterns found in animals by engineering synthetic gene networksRecreating the stripe patterns found in animals by engineering synthetic gene networks

Laying the groundwork for data-driven scienceLaying the groundwork for data-driven science

Nature's designs inspire research into new light-based technologiesNature's designs inspire research into new light-based technologies

Missing piece found to help solve concussion puzzleMissing piece found to help solve concussion puzzle

Biologists delay the aging process by 'remote control'Biologists delay the aging process by 'remote control'

Geography matters: Model predicts how local 'shocks' influence U.S. economyGeography matters: Model predicts how local 'shocks' influence U.S. economy

Identified for the first time what kind of explosive has been used after the detonationIdentified for the first time what kind of explosive has been used after the detonation

Copied from nature: Detecting software errors via genetic algorithmsCopied from nature: Detecting software errors via genetic algorithms

Study sheds light on pregnancy complications and overturns common belief (7/12/2012)

Tags:
pregnancy
'Many doctors may be unnecessarily treating some pregnant women who have antiphospholipid antibodies (aPLs) with anticoagulants, such as expensive heparin injections, which can cause bleeding and bone loss, explained Dr. Jane Salmon, the paper's senior author. -  Hospital for Special Surgery
'Many doctors may be unnecessarily treating some pregnant women who have antiphospholipid antibodies (aPLs) with anticoagulants, such as expensive heparin injections, which can cause bleeding and bone loss, explained Dr. Jane Salmon, the paper's senior author. - Hospital for Special Surgery

A study led by Hospital for Special Surgery researchers has demonstrated that women who have a specific type of antibody that interferes with blood vessel function are at risk for adverse pregnancy outcomes and that other antibodies in the same family thought to cause pregnancy complications do not put women at risk.

The researchers say that many doctors may be unnecessarily treating some pregnant women who have antiphospholipid antibodies (aPLs) with anticoagulants, such as expensive heparin injections, which can cause bleeding and bone loss. The multicenter study appears in the July 2012 issue of the journal Arthritis & Rheumatism.

"This paper identifies people who are at risk for pregnancy loss and, more importantly, those who are not at risk and who therefore do not need to be treated," said Michael Lockshin, M.D., director, Barbara Volcker Center for Women and Rheumatic Disease, and co-director, Mary Kirkland Center for Lupus Research at Hospital for Special Surgery (HSS), New York City, and lead author of the study.

Antiphospholipid antibodies interfere with phospholipids, a type of fat found in all living cells and cell membranes, including blood cells and the lining of blood vessels. Patients with these antibodies are at risk for blood clots, stroke, and pregnancy complications, but some patients with these antibodies can be completely healthy. "Phospholipids are highly exposed in the placenta, and as a result antiphospholipid antibodies concentrate there," said Jane Salmon, M.D., the study's senior author and Collette Kean Research Chair and co-director, Mary Kirkland Center for Lupus Research at HSS. "When antibodies are deposited in a person's tissues, inflammation is initiated leading to organ damage." And this is a mechanism for pregnancy complications.

Women who have recurrent pregnancy loss are commonly tested for the presence of aPLs, and up to 15% are positive. Most patients who test positive are treated with anticoagulants. Currently, there are no standards regarding which aPLs doctors test for to assess risk (there are three main ones) and interlaboratory consistency of results is poor.

The new study is the first clinical research publication of the PROMISSE study, an ongoing multicenter, prospective clinical trial comparing the pregnancies of women with aPL, lupus, both aPL and lupus, and healthy controls. Between 20% and 35% of patients with lupus and aPL have pregnancy complications and the study is attempting to identify which patients are at risk.

"The identification of biomarkers that identify patients at high risk will allow us to select a subset of patients who we can consider in an interventional trial," said Dr. Salmon, the principal investigator of PROMISSE. This PROMISSE study, which involves over 700 patients from nine centers in North America, is funded by the National Institute of Arthritis, Musculoskeletal and Skin Diseases of the National Institutes of Health. A strength of PROMISSE is that all aPL tests were sent to core laboratories, eliminating interlaboratory variability.

The current analysis focused on 144 patients who had aPLs, of whom 28 had adverse pregnancy outcomes. A control group, 159 healthy pregnant women, was tested parallel to the group with aPLs. Controls were selected among women with no known illness, no prior fetal loss, no more than one miscarriage and at least one successful pregnancy.

The study examined the association between adverse pregnancy outcome and the presence of three different aPLs: lupus anticoagulant [LAC], anticardiolipin antibody [aCL] and antibody to β2 glycoprotein I. An adverse pregnancy outcome was defined as otherwise unexplained fetal death after 12 weeks, neonatal death prior to discharge that was associated with complications of prematurity, preterm delivery prior to 34 weeks because of gestational hypertension, preeclampsia or placental insufficiency, and birthing a child that was small for its gestational age.

The researchers found that LAC was the strongest predictor of an adverse pregnancy outcome; 39% of patients with LAC had an adverse outcome compared to 3% who did not have LAC (P<0.0001). Only 8% of women with aCL, but not LAC, suffered an adverse outcome. Other aPLs did not increase risk. "Lupus anticoagulant is the most important predictor of risk and high titer anticardiolipin antibodies alone don't provide substantial risk," said Dr. Salmon. She noted that prior to this study, many physicians considered aCL as a potent predictor of risk.

Anticoagulant treatments are currently used for many women with aPLs, but identifying who to treat is not clear and this treatment is often ineffective. "Although many patients with aPLs are treated with heparin, pregnancy outcomes are still disappointing. We need better therapies," said Dr. Salmon. "This study will allow us to identify subsets of patients with the highest risk in whom to test new approaches and new drugs."

Dr. Salmon's studies in mice with aPL have shown that blocking inflammatory pathways can prevent miscarriages, growth restriction and preeclampsia. Further studies on samples from PROMISSE patients, followed by interventional trials will hopefully shed light on whether this therapeutic approach will be effective in pregnant women with aPLs and/or lupus.

Note: This story has been adapted from a news release issued by the Hospital for Special Surgery

Post Comments:

Search
New Articles
Certain parenting tactics could lead to materialistic attitudes in adulthoodCertain parenting tactics could lead to materialistic attitudes in adulthood

Even expectant dads experience prenatal hormone changes

A 2-minute delay in cutting the umbilical cord leads to a better development of newborns

Study finds low weight gain in pregnant women reduces male fetal survivalStudy finds low weight gain in pregnant women reduces male fetal survival

Prenatal exposure to common household chemicals linked with substantial drop in child IQ

Are you helping your toddler's aggressive behavior?

Punishing kids for lying just doesn't work

Higher birth weight indicates better performance in school

Are the benefits of breast milk stimulant worth the risk?

Many chest X-rays in children are unnecessaryMany chest X-rays in children are unnecessary

Why does physical activity during childhood matter?

Heavier newborns show academic edge in school

Why don't children belong to the clean plate club?Why don't children belong to the clean plate club?

New study examines the effect of timing of folic acid supplementation during pregnancy

Full-day preschool linked with increased school readiness compared with part-day



Archives
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010




Science Friends
Agricultural Science
Astronomy News
Biology News
Biomimicry Science
Cognitive Research
Chemistry News
Tissue Engineering
Cancer Research
Cybernetics Research
Electonics Research
Forensics Report
Fossil News
Genetic Archaeology
Genetics News
Geology News
Nanotech News
Microbiology Research
Physics News
  Archives |  Submit News |  Advertise With Us |  Contact Us |  Links
Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All contents © 2000 - 2019 ParentingBulletin.com. All rights reserved.